ARGX:NASDAQ
argenx SE - ADR
$1,033.15
arrow_downward
-1.93%(-20.31) 1D
$1,033.15
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 4, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$1,040.31
High
$1,048.44
Low
$1,031.19
Mkt. cap
64.86B
Avg. vol.
289.94K
Volume
125.06K
P/E ratio
39.25
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
Open
$1,040.31
High
$1,048.44
Low
$1,031.19
Mkt. cap
64.86B
Avg. vol.
289.94K
Volume
125.06K
P/E ratio
39.25
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$26.32
Beta
0.47
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
45 minutes ago
Argenx stock heads into the open after a 2.1% drop
AD HOC NEWS
·
2 days ago
Argenx stock holds steady after latest rare disease setback in sector
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR